O
ABBV icon

OppenheimerFunds’s AbbVie ABBV Stock Holding History

OppenheimerFunds’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$3.09M Buy
38,329
+4,593
+14% +$376K ﹤0.01% 814
2018
Q4 		$3.11M Buy
33,736
+2,457
+8% +$216K ﹤0.01% 799
2018
Q3 		$2.96M Sell
31,279
-246,320
-89% -$23.4M ﹤0.01% 842
2018
Q2 		$25.7M Sell
277,599
-111,896
-29% -$10.9M 0.03% 519
2018
Q1 		$36.9M Sell
389,495
-21,974
-5% -$2.41M 0.05% 397
2017
Q4 		$39.8M Sell
411,469
-133,655
-25% -$12.6M 0.05% 376
2017
Q3 		$48.4M Sell
545,124
-57,108
-9% -$4.35M 0.06% 310
2017
Q2 		$43.7M Sell
602,232
-130,091
-18% -$8.75M 0.05% 335
2017
Q1 		$47.7M Sell
732,323
-290,723
-28% -$18.3M 0.06% 317
2016
Q4 		$64.1M Sell
1,023,046
-22,145
-2% -$1.35M 0.08% 258
2016
Q3 		$65.9M Buy
1,045,191
+57,944
+6% +$3.75M 0.08% 269
2016
Q2 		$61.1M Buy
987,247
+82
+0% +$5K 0.08% 275
2016
Q1 		$56.4M Buy
987,165
+186,261
+23% +$10.4M 0.07% 276
2015
Q4 		$47.5M Buy
800,904
+214,664
+37% +$12.4M 0.06% 349
2015
Q3 		$31.9M Buy
586,240
+19,915
+4% +$1.3M 0.04% 429
2015
Q2 		$38.1M Sell
566,325
-466,025
-45% -$30.4M 0.04% 414
2015
Q1 		$60.4M Sell
1,032,350
-4,247,271
-80% -$257M 0.07% 330
2014
Q4 		$345M Buy
5,279,621
+66,913
+1% +$4.22M 0.38% 64
2014
Q3 		$301M Sell
5,212,708
-138,518
-3% -$7.69M 0.33% 76
2014
Q2 		$302M Buy
5,351,226
+607,026
+13% +$31.8M 0.33% 76
2014
Q1 		$244M Sell
4,744,200
-39,502
-0.8% -$2M 0.29% 94
2013
Q4 		$253M Sell
4,783,702
-1,801,664
-27% -$88.5M 0.31% 85
2013
Q3 		$295M Buy
6,585,366
+2,955,381
+81% +$131M 0.2% 132
2013
Q2 		$150M Buy
+3,629,985
New +$159M 0.22% 123

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

OppenheimerFunds's ABBV Position: Q1 2019 in Review

OppenheimerFunds increased its AbbVie (ABBV) stake by 14% in Q1 2019, buying an estimated $376K and bringing the position to 38,329 shares worth $3.09M. The position accounts for ﹤0.01% of the portfolio, ranked #814.

OppenheimerFunds first reported a position in ABBV in Q2 2013 and has held it in 24 quarters since. The position peaked at $345M in Q4 2014. 2,034 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

  • OppenheimerFunds held 38,329 shares of AbbVie worth $3.09M as of Q1 2019.
  • OppenheimerFunds bought 4,593 AbbVie shares in Q1 2019, an estimated $376K.
  • AbbVie made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #814 holding.
  • OppenheimerFunds first reported a position in AbbVie in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's AbbVie position peaked at $345M in Q4 2014.
  • 2,034 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.